A new modelling study published in the British Medical Journal projects a significant increase in the prevalence of Parkinson’s disease by 2050. Globally, the number of individuals living with Parkinson’s disease is expected to more than double, reaching approximately 25.2 million by 2050, a 112% increase from 2021.

A recent study by the University of Eastern Finland Business School found that elderly neurological patients are generally receptive to in-home remote monitoring technologies. Remote monitoring offers an opportunity to complement the clinical assessment and help clinicians get a more holistic view of a patient’s condition over an extended period and at home.

Today marks World Parkinson's Day, a day dedicated to raising awareness about Parkinson's disease, honoring those living with the condition, and recognizing the invaluable contributions of researchers, healthcare professionals, therapy developers, caregivers, friends, and advocates working to improve treatment and care.

The Adamant Health measurement and analysis service complements clinical assessment and helps clinicians get a more holistic view of a patient’s condition by collecting symptom data over an extended period of time and at home.

Are you passionate about clinical trials and regulatory compliance? Join our team as Clinical Trial Manager and contribute to groundbreaking medical device research while working in a fast-paced, collaborative environment.

We have been working with our supplier to enhance the measurement device for the Adamant Health measurement and analysis service and developing our software application to make our service even easier for healthcare professionals to use. In addition, we have released a new patient diary, particularly developed for people with Parkinson’s disease.

2024 has been an extraordinary year for Adamant Health. As the year draws to a close, we’d like to thank you for your cooperation and support throughout the year. As we pause to spend time with family and friends during the holidays, we wish you a happy, healthy holiday season and a wonderful New Year!

Movement disorders are neurologic conditions that can be especially difficult to diagnose, treat, and understand. World Movement Disorders Day, taking place on November 29, is an annual event to raise awareness about movement disorders. The global effort is managed by the International Parkinson and Movement Disorder Society and its partners.

Tech Tour has chosen Adamant Health as one of the innovative companies with the potential to transform the healthcare industry through AI. We are excited to present our groundbreaking technology for data-driven management of Parkinson's disease at Tech Tour AI for Health 2024 on 22-23 January 2025 in Bochum, Germany.

Adamant Health has been selected as a Deep Tech Pioneer by Hello Tomorrow out of 4,600 applications from 120 countries. Hello Tomorrow is the largest network of deep tech startups, investors, and the most innovative private & public organizations helping deep tech startups and corporations build new solutions.

Adamant Health is growing and entering a new phase in its journey, and we are now looking for a person to work as a Data Analyst & Scientist for the company. In this role, you will analyze the data measured from the patient with our leading measurement and analysis service and create symptom reports used by our customers.

The new patient diary, particularly developed for the Adamant Health measurement and analysis service, offers an easy and secure way to collect accurate information on the patient's medication intakes, symptoms, and well-being for clinical use.

We are proud that Adamant Health is one of twelve selected Finnish healthcare companies for the AMPlify – Accelerated US Market Entry program 2024. The program designed by Business Finland in collaboration with Mayo Clinic aims to support Finnish healthcare companies in accessing the US market and shorten their time to market.

Adamant Health has been selected for the 2024 US MedTech program in the Nordic Mentor Network For Entrepreneurship. Adamant Health's acceptance to the program is a testament to our groundbreaking research and highly advanced technology, and we are looking forward to connecting with the world-class mentors that are selected from among the best life science experts in the Nordics and the US.

Anne Fraser-Vatto has joined the Adamant Health team as the new Director, Finance & Operations. Anne has over 20 years of experience in finance and operations, including with international growth companies.

Tekniikan Maailma features ten Finnish health technology companies providing innovative solutions for the benefit of the patient – Adamant Health with its unique measurement and analysis service for Parkinson's disease being one of them.

As the Director of Finance and Operations, you will play a critical role in shaping the financial and operational strategies of Adamant Health. This position offers a unique blend of financial management and operational involvement, making it ideal for those who thrive in a dynamic and evolving environment.

Today is World Parkinson's Day, a day dedicated to raising awareness for the disease and paying tribute to people living with the condition every day! Parkinson’s disease is the fastest-growing neurological disorder in the world, affecting people of all races and cultures.

April marks Parkinson’s Awareness Month, a time dedicated to increasing awareness about and elevating the conversation around Parkinson's disease, a neurological disorder that progressively impairs movement and function, affecting millions worldwide.

On Saturday, we had the honor to celebrate the Finnish Movement Disorders Association’s 40th anniversary together with over 200 guests, including people diagnosed with movement disorders and their relatives.